# A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-201 Clinical Trial

> **NCT03183804** · — · COMPLETED · sponsor: **Anterogen Co., Ltd.** · enrollment: 54 (estimated)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **BIOLOGICAL:** ALLO-ASC-DFU
- **OTHER:** Standard therapy

## Key facts

- **NCT ID:** NCT03183804
- **Lead sponsor:** Anterogen Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-29
- **Primary completion:** 2018-08-17
- **Final completion:** 2018-10-24
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2023-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03183804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03183804, "A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-201 Clinical Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03183804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*